Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06541756

Fibrine Clot-augmented Repair of Longitudinal Meniscus Tears

Longitudinal meniscal tears are a type of meniscal injury characterized by a displaced fragment of the meniscus that flips over into the joint, often resembling a buckle or handle. These tears typically occur in the medial meniscus and are often associated with traumatic knee injuries, particularly in athletes.

The displaced meniscal fragment can cause mechanical symptoms such as locking, clicking, or catching of the knee, as well as pain and swelling. If not properly treated, buckle-handle meniscal tears can lead to further complications, including chronic knee instability, increased risk of osteoarthritis, and persistent joint pain.Repairing a longitudinal meniscal tear offers several advantages over partial meniscectomy, particularly in preserving knee function and preventing long-term complications.

Meniscal repair aims to restore the integrity of the meniscus, which plays a crucial role in load distribution, shock absorption, and joint stability.

Utilizing a fibrin clot during the repair of a buckle-handle meniscal tear can enhance the healing process and improve surgical outcomes. Fibrin clots act as a biological scaffold, promoting tissue regeneration by providing a matrix that facilitates cellular migration and proliferation.

The purpose of this study was to compare longitudinal meniscal tear repair reinforced with fibrin clot with routine end-to-end repair in a prospective randomized controlled trial.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ankara Bilkent City Hospital, Ankara, Turkey (Türkiye)

Loading trial locations.

About this study

This study is designed as a prospective randomized controlled clinical trial. It aims to include patients presenting to the Orthopedics and Traumatology clinics at Ankara Bilkent and Etlik City Hospitals with longitudinal meniscus tears between August 2024 and December 2028. Participants will be randomly assigned to one of two groups: one receiving meniscus repair with fibrin clot reinforcement and the other receiving standard repair.

Patients in the standard repair group will undergo routine meniscus repair surgery using arthroscopic all-inside or inside-out sutures, with spinal anesthesia. For the fibrin clot group, a fibrin clot will be prepared from 50cc of bone marrow aspirate obtained from the iliac crest and mixed for 15 minutes. The fibrin clot will be shaped into a cylindrical form and compressed between the torn edges of the meniscus using a trocar system, then secured with sutures. After completing the repairs, the surgical wounds and portals will be closed, and an elastic bandage will be applied. The post-operative rehabilitation protocols will be the same for all patients.

Patients will be clinically followed for at least one year, with healing rates compared using control magnetic resonance imaging at the end of the first year.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presenting with a painful meniscus (lateral or medial) longitudinal tear
  • Being between the ages of 18 and 50
  • Not having undergone surgery on the same knee before
  • Having an MRI taken at the end of the 1st year post-surgery

Exclusion criteria

  • Having additional collateral ligamentous damage along with the meniscus tear (such as MCL or LCL)
  • Incomplete clinical scores at the end of the study
  • A history of previous surgery on the same knee
  • Having an active infection
  • Not having a control MRI at the end of the 1st year

Treatment and study plan

Fibrine Clot-augmented Meniscal Repair

Procedure

The fibrin clot will be prepared from 50cc of bone marrow aspirate obtained from the iliac crest and mixed for 15 minutes. The fibrin clot will be shaped into a cylindrical form and compressed between the torn edges of the meniscus using a trocar system, then secured with sutures.

Conventional Meniscal Repair

Procedure

Patients in the standard repair group will undergo routine meniscus repair surgery using arthroscopic all-inside or inside-out sutures.

Primary outcomes

  1. Number of patients with a healed meniscus on MRI

    Time frame: Postoperative 1st year

    Meniscal healing at 1 year follow up as detected on the control MRI (yes / no / partial)

Secondary outcomes

  1. Tegner Activity Scale

    Time frame: Postoperative 1.st year

    minimum value:0, maximum value 10, higher values mean better outcome

  2. The Knee injury and Osteoarthritis Outcome Score (KOOS)

    Time frame: Postoperative 1.st year

    minimum value:0, maximum value 100, higher values mean better outcome

  3. Tegner-Lysholm Score

    Time frame: Postoperative 1.st year

    minimum value:0, maximum value 100, higher values mean better outcome

Study contacts

Contact information is provided by the study sponsor or research team.

Enejd Veizi, MD

CONTACT

[email protected]

+905439799959

Yasin Erdoğan, MD

CONTACT

[email protected]

+905056056097

Sponsors and collaborators

Lead sponsor

Ankara City Hospital Bilkent

Other

Collaborators

  • Ankara Etlik City Hospital

Registry information

Official study title

Fibrine Clot-augmented Repair of Longitudinal Meniscus Tears - A Prospectively Randomized Controlled Trial

Acronym: FCAR

Important dates

Study start
2024
Primary completion
2028
Study completion
2029
First posted
Aug 7, 2024
Registry last updated
Oct 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.